2021
DOI: 10.1128/aem.00471-21
|View full text |Cite
|
Sign up to set email alerts
|

Genes Encoding Microbial Acyl Coenzyme A Binding Protein/Diazepam-Binding Inhibitor Orthologs Are Rare in the Human Gut Microbiome and Show No Links to Obesity

Abstract: Acyl coenzyme A (CoA) binding protein (ACBP), also called diazepam-binding inhibitor (DBI) is a phylogenetically conserved protein that is expressed by all eukaryotic species as well as by some bacteria. Since elevated ACBP/DBI levels play a major role in the inhibition of autophagy, increase in appetite and lipoanabolism that accompany obesity, we wondered whether ACBP/DBI produced by the human microbiome might affect host weight. We found that the genomes of bacterial commensals rarely contain ACBP/DBI homol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 73 publications
(103 reference statements)
0
6
0
Order By: Relevance
“…On the other hand, Oscillibacter sp. 57_20 was found to associate with decreased BMI [ 25 ]. Notably, a significant decrease in the abundance of the genus Oscillibacter was observed in newly diagnosed acromegaly patients with adenoma in the pituitary gland [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, Oscillibacter sp. 57_20 was found to associate with decreased BMI [ 25 ]. Notably, a significant decrease in the abundance of the genus Oscillibacter was observed in newly diagnosed acromegaly patients with adenoma in the pituitary gland [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
“…Acyl‐coenzyme A binding protein (ACBP), which is encoded by a diazepam‐binding inhibitor (DBI), is a leaderless polypeptide that can be secreted unconventionally during the activation of autophagy (Bravo‐San Pedro, Sica, Martins, Anagnostopoulos, et al, 2019 ; Duran et al, 2010 ; Manjithaya et al, 2010 ). ACBP/DBI is a phylogenetically conserved protein, the existence of which has been documented in prokaryotes (in particular in eubacteria) as well as in all major eukaryotic kingdoms including animals, fungi, and plants (Du et al, 2016 ; Thomas et al, 2021 ). Its autophagy‐dependent release has been reported in unicellular and multicellular fungi (Duran et al, 2010 ; Manjithaya et al, 2010 ) as well as in human and murine cells (Bravo‐San Pedro, Sica, Martins, Anagnostopoulos, et al, 2019 ; Loomis et al, 2010 ).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, induction of polyclonal autoantibodies capable of neutralizing ACBP/DBI failed to induce visible side effects over several months. It is remarkable, however, that the liver disease–attenuating effects of α-DBI are mimicked by those of the inducible Dbi knockout, constitutive mutation of the ACBP/DBI receptor, as well as by the induction of autoantibodies, strongly arguing in favor of the hypothesis that α-DBI acts on target rather than by recognizing additional host genome–encoded or microbial proteins that structurally resemble ACBP/DBI ( 60 , 61 ).…”
Section: Discussionmentioning
confidence: 99%